Circulating GFAP emerged as a sensitive but non-specific biomarker of neuroglial injury.<h4>Conclusion</h4>CTE is best conceptualized as a neuroglial tauopathy in which astrocytes function as integral contributors to disease progression, likely in coordination with microglia. Here, GFAP is linked to tauopathy.